Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2002, p. 2823-2827, Vol. 40, No. 8
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.8.2823-2827.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Programme in Infectious Diseases, Department of Microbiology, Faculty of Medicine, National University of Singapore, Singapore 117597,1 Department of Pathology, Singapore General Hospital, Singapore 1696082
Received 7 March 2002/ Returned for modification 8 April 2002/ Accepted 14 May 2002
|
|
|---|
|
|
|---|
In view of its high sensitivity and specificity, reverse transcription-PCR (RT-PCR) is beneficial for the rapid detection of enterovirus 71 (EV71) in outbreak situations. The rapid establishment of enteroviral etiology would eliminate the unnecessary use of antibiotics and lead to better patient management. Early diagnosis can help to limit the spread of the disease in the community during an outbreak. The aim of this study was to identify the etiological agents involved in the HFMD outbreak. We investigated the applicability of RT-PCR by using universal pan-enterovirus and type-specific primers for the direct detection of EV71 in clinical specimens. Direct sequencing of RT-PCR products amplified from the 5' untranslated region (5' UTR) by using universal primers (10, 16) was compared with a newly developed seminested RT-PCR assay based on specific primers targeting the VP1 region of EV71.
(Part of this work was presented at the 10th International Congress on Infectious Diseases, 2002.)
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Comparative detection of enteroviruses in clinical specimens by cell culture and two RT-PCR assays
|
Seminested PCR amplification. The first-round PCR was carried out using the EV71 type-specific primer pair VP1F2 (5'-GTTCTTAACTCACATAGCA-3', corresponding to nucleotides 2646 to 2664 of 7423/MS/87) and EV71R2 (5'-TTGACAAAAACTGAGGGGTT-3', nucleotides 2986 to 2967) under PCR conditions described previously by Singh et al. (12). The second-round seminested PCR was performed using primers VP1F2 and 162A (5'-CCRGTAGGKGTRCACGCRAC-3', nucleotides 2872 to 2853) (3). The second amplification was carried out under the same conditions as the first, except that 1 µl of the first-round PCR product was added to 49 µl of PCR mixture and a total of 35 cycles were used.
Nucleotide sequence analysis. Purified products were cycle sequenced using the ABI PRISM Big Dye Terminator cycle sequencing ready reaction kit. DNA sequencing was performed using the ABI PRISM 377 DNA sequencer (Applied Biosystems). Homology searches were carried out using the BLAST algorithm (http://www.ncbi.nlm.nih.gov/BLAST). The percentage of sequence identity was calculated using the Blast 2 Sequences program, which permits alignment of two given sequences by using the BLAST engine for local alignment (13).
Nucleotide sequence accession numbers. The 5' UTR sequence data for 10 strains derived from nine different patients were deposited in the GenBank database under the accession numbers shown in Table 1.
|
|
|---|
EV71 was detected directly from clinical and autopsy specimens such as the brains, hearts, and lungs of two dead siblings (i.e., patients 21 and 22) who had encephalitis, myocarditis, interstitial pneumonitis, and pulmonary edema. A positive EV71 amplicon was also detected from the rectal swab of another deceased patient, no. 20. RT-PCR failed to generate any positive amplicons from four autopsy samples from deceased patient 19, thus suggesting either the involvement of a virus other than enterovirus or an enteroviral titer too low to allow any detection.
The 154-bp amplicons derived from the 5' UTRs of 10 specimens were sequenced and compared with sequences of known enteroviral strains isolated elsewhere via computational analysis. As shown in Table 1, one of the strains was genotypically recognized as coxsackievirus A16 or CA16 (patient 2), with 97% nucleotide similarity. Coxsackievirus B4 was genotypically identified in another patient (no. 5), with 94% nucleotide identity. EV71 sequences were identified in eight other clinical specimens from different patients, with the 154-bp amplicons showing 96 to 97% nucleotide similarity to EV71 strains previously isolated in Singapore (12). The enteroviruses detected in specimens derived from three of the fatal cases were also genotypically identified as EV71.
EV71 nucleotide sequences identified in clinical specimens from the two deceased siblings correlated with serotyping data by neutralization assays (Table 1). Twenty-three specimens from which no positive amplicons were generated with the universal primers also failed to produce any cytopathic effect in cell cultures. However, a significant number of specimens (another 21) failed to yield any virus isolate in cell cultures but were positive by RT-PCR with universal primers, thereby substantiating the potential of molecular amplification for detecting a low viral load or even nonviable virions present in clinical specimens.
RT-PCR assay using EV71 type-specific primers. While sequencing of the 154-bp RT-PCR products following amplification of the 5' UTR with universal pan-enterovirus primers can provide accurate identification of enterovirus types, it is still too time-consuming and costly to sequence large numbers of isolates in outbreak situations. As a significant number of samples from the present outbreak were sequenced and identified to be EV71, we saw an opportunity to evaluate type-specific primers for direct detection of EV71 in clinical specimens. EV71-specific primers that target the VP1 region have shown high specificity and sensitivity for detecting EV71 isolates derived from cell cultures (3, 8, 12, 14). However, there is a scarcity of data available regarding the specificity and sensitivity of these primers for RT-PCR performed directly on clinical material.
To test the efficacy of EV71 type-specific primers, experiments were performed using two primer pairs, 92S-93A and 159S-162A with mixed base composition, designed by Brown et al. (3), as well as VP1F2 and EV71R2, designed by Singh et al. (12). Twenty-seven cell culture isolates were studied, including the prototype EV71/7423/MS/87 strain, 2 EV71 isolates from the recent outbreak, 19 endemic EV71 strains isolated previously in Singapore (12), 3 coxsackievirus A16 strains, and 2 echovirus 30 strains (Table 2). The primer pair VP1F2-EV71R2 generated positive amplicons for 82% (18 of 22) of EV71 isolates. The primer pair 159S-162A yielded positive amplicons for all of the EV71 isolates. Neither primer pair amplified any coxsackievirus A16 or echovirus 30, thus reiterating their high specificity for EV71. The primer pair 92S-93A generated amplicons in only 14% (3 of 22) of the EV71 isolates. However, 92S-93A also amplified CA16 and echovirus 30 and therefore was not completely specific for EV71. The primer pairs VP1F2-EV71R2 and 159S-162A were then further evaluated using 26 representative clinical specimens from HFMD patients from the outbreak (Table 1). Only one (3.8%) specimen from patient no. 13 tested positive by RT-PCR with either the VP1F2-EV71R2 or the 159S-162A primer pair.
|
View this table: [in a new window] |
TABLE 2. Cell culture isolates tested by single-round RT-PCR with EV71 type-specific primers
|
Detection of EV71 by cell culture isolation and neutralization tests exhibited 100% correlation with the RT-PCR data with pan-enterovirus primers. Out of the 17 specimens identified as EV71 by seminested PCR, 4 correlated well with cell culture results, while 10 correlated well with RT-PCR with universal primers. The EV71 detection rates were 35% (17 of 48) for seminested PCR, compared to 49% (25 of 51) for RT-PCR with pan-enterovirus primers and 14% (7 of 51) by cell culture isolation.
Out of the 51 clinical specimens tested for the presence of enteroviruses by the two amplification techniques or by cell culture isolation, no viable nor nonviable enterovirus was detected in 31% (16 of 51) of specimens. Enteroviruses were recovered from only seven clinical specimens, and all were serotyped as EV71 by neutralization tests. No cytopathic changes were observed in the other specimens even after repeated passages in RD and HeLa cells. The remaining 35 specimens were shown to contain viable or nonviable enteroviruses by cell culture and/or RT-PCR methods and were considered true positives for enteroviruses. However, sequencing of the amplicons of RT-PCR with universal primers revealed EV71 sequences in 32 specimens but not in another three. Taking these findings into consideration, the detection rate by RT-PCR using universal primers and sequencing increased to 71% (25 of 35), versus only 20% (7 of 35) by cell culture and neutralization tests (Table 3). Direct detection of EV71 by seminested RT-PCR was successful in 53% (17 of 32) of clinical specimens, while RT-PCR using specific primer pairs (3, 12) yielded a very low positivity rate of only 4.8% (1 of 21).
|
View this table: [in a new window] |
TABLE 3. Comparison of diagnostic positivity by cell culture versus RT-PCR assays for the direct detection of EV71 from clinical specimensa
|
|
|
|---|
The need for accurate and rapid diagnostic tests for EV71 infection is widely appreciated and was fulfilled by the use of the universal enterovirus primer pair for RT-PCR and for sequencing of the 154-bp amplicons. This combination could genotypically identify enteroviruses directly from a broad range of clinical specimens, including autopsy specimens of the brains, hearts, and lungs from two deceased siblings. Out of the 35 true-positive specimens, 71% (25 of 35) were confirmed to be EV71 by cell culture as well as by RT-PCR and sequencing with universal primers. However, one has to consider that many specimens tested for the presence of enteroviruses were from tissues that do not usually support virus replication, and the virus may not be readily detected by RT-PCR. If more samples such as stool, rectal swabs, and throat swabs were collected, the percentage of positive results may be significantly higher.
Both pairs of EV71 type-specific primers, VP1F2-EV71R2 and 159S-162A, were able to detect isolates of the prototype strain 7423/MS/87, endemic EV71 strains isolated previously, and two EV71 strains from the outbreak. Primer pair 159S-162A was more sensitive than VP1F2-EV71R2 and 92S-93A for detecting EV71 strains endemic in Singapore. The mixed base composition of the primer pair 159S-162A could account for its 100% sensitivity for detecting EV71 isolates compared to the 82% sensitivity of primer pair VP1F2-EV71R2. Although both primer pairs showed relatively high sensitivity for testing isolates of EV71, the sensitivity of RT-PCR with these primers for the direct detection of EV71 in clinical specimens was a very low 5%. Degradation of the viral genome due to the presence of RNases in clinical specimens or an extremely low virus load could explain nondetection. Another possible explanation for this discrepancy is primer-template mismatches arising from genetic diversity of the capsid genes of EV71 strains encountered in the outbreak, despite the primer pair 159S-162A being designed to accommodate base changes.
Conventional PCR is not as sensitive as seminested or nested PCR, and the results may be misleading. Furthermore, seminested PCR offers potentially greater sensitivity in direct testing of clinical specimens (4). The greater sensitivity of seminested PCR could detect EV71 in seven clinical specimens that tested negative either by cell culture or by RT-PCR using universal primers. The primers employed in the newly developed seminested PCR were highly specific, by generating 227-bp amplicons diagnostic for EV71. The target amplicons derived from the VP1 region were authenticated by direct sequencing and displayed 97 to 100% identity to endemic EV71 strains. In the outbreak, our seminested PCR assay proved to be feasible for EV71 detection directly from clinical specimens, with rapid confirmation achievable within a day.
As HFMD outbreaks are often caused by cocirculation of EV71 and CA16 (14), our EV71 type-specific seminested PCR primers can complement the CA16-specific primers designed by Bendig et al. (2) in RT-PCR assays for the rapid detection of these two serotypes in clinical specimens. The prompt recognition of EV71 infections, which in recent years have been associated with more serious illness and higher fatalities than those caused by CA16, will enable immediate intervention and severance of the transmission chain in an epidemic.
Prolonged storage of clinical specimens and delays in their transportation to the laboratory may have resulted in a gradual decline in viral titer and affected the intensity of some amplified products. The enteroviral RNA genome is extremely susceptible to degradation by ubiquitous RNases present in body fluids and tissues. The higher detection by seminested PCR may be attributed to the further amplification of the first PCR product, which was initially below the level of detection. When viral isolation remains negative due to nonviability of viruses in clinical specimens, nested PCR assays are ideal for the molecular identification of enteroviral agents responsible for an outbreak (4). Provided that stringent precautions are adopted to avoid contamination, seminested and nested PCR assays are particularly useful for clinical samples such as cerebrospinal fluid, in which low viral copy numbers may be present (4), thus yielding genetic evidence for the diagnosis of HFMD with neurological involvement.
This study was supported by research grant no. NMRC/0400/2000 from the National Medical Research Council, Singapore. S. Singh is the recipient of a research scholarship from the National University of Singapore.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»